Hepalink Pharmaceutical Group Co., Ltd. has earned recognition in the 2026 ISPE Facility of the Year Awards (FOYA) Innovation – Novel Technology category for its groundbreaking Shenzhen Hepalink Pingshan New Pre-filled Syringe Manufacturing Facility. The award recognizes facilities that demonstrate the innovative application of manufacturing technologies, facility design, and engineering...
AstraZeneca’s Commercial Cell Therapy Facility in Rockville, Maryland is setting a new benchmark for how pharmaceutical manufacturers can deliver lifesaving therapies while simultaneously advancing sustainability and operational excellence. Recognized as the 2026 ISPE Facility of the Year Awards (FOYA) Social Impact – Unmet Medical Needs Category Winner, the facility demonstrates how...
As antibody-drug conjugates (ADCs) continue to transform cancer treatment, manufacturers face increasing pressure to deliver these highly complex therapies faster, more safely, and with greater reliability. Yet one of the industry's most persistent challenges remains the fragmented supply chain traditionally required to produce ADCs.
As pharmaceutical manufacturers work to deliver increasingly complex therapies while improving efficiency, sustainability, and worker safety, facilities must evolve to support entirely new approaches to drug production. Chugai Pharma Manufacturing’s FJ3 Project demonstrates how innovative facility design can help overcome long-standing manufacturing limitations while accelerating patient...
As the pharmaceutical industry works to reduce its environmental footprint while continuing to deliver life-transforming therapies to patients worldwide, organizations are increasingly seeking solutions that balance operational performance, sustainability, and long-term resilience. Takeda’s AHEAD – Advanced Heat Pump Demonstrator project represents a powerful example of what is possible when...
